You are viewing the site in preview mode

Skip to main content

Table 5 Antibiotic resistance stratified by bacteria isolated

From: Emerging antibiotic resistance in bacterial bloodstream infections: a clinical study at the Holy Family Hospital, Nkawkaw, Ghana

Bacteria isolated

Antibiotics

Citrobacter species

n (%)

E. coli

n (%)

Klebsiella species

n (%)

Proteus mirabilis

n (%)

Pseudomonas species

n (%)

Staphylococcus aureus

n (%)

Serratia species

n (%)

Coagulase-negative Staphylococcus

n (%)

Total

n (%)

PEN

         

R

0(0.0)

10(11.9)

13(15.5)

0(0.0)

1(1.2)

42(50.0)

1(1.2)

17(20.2)

84(100.0)

S

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

3(42.9)

0(0.0)

4(57.1)

7(100.0)

COX

         

R

0(0.0)

3(7.9)

8(21.1)

0(0.0)

0(0.0)

17(44.7)

0(0.0)

10(26.3)

38(100.0)

S

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

5(71.4)

0(0.0)

2(28.6)

7(100.0)

CIP

         

I

0(0.0)

0(0.0)

1(100.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(100.0)

R

0(0.0)

15(27.3)

15(27.3)

0(0.0)

2(3.6)

11(20)

0(0.0)

12(21.8)

55(100.0)

S

5(2.9)

31(18.1)

58(33.9)

0(0.0)

11(6.4)

46(26.9)

2(1.2)

18(10.5)

171(100.0)

AUG

         

R

0(0.0)

6(12.0)

9(18.0)

0(0.0)

3(6.0)

22(44.0)

0(0.0)

10(20.0)

50(100.0)

S

0(0.0)

1(6.3)

0(0.0)

0(0.0)

0(0.0)

11(68.8)

0(0.0)

4(25.0)

16(100.0)

MEM

         

R

6(6.5)

21(22.8)

34(37)

0(0.0)

7(7.6)

18(19.6)

1(1.1)

5(5.4)

92(100.0)

S

0(0.0)

4(16.7)

4(16.7)

0(0.0)

1(4.2)

13(54.2)

0(0.0)

2(8.3)

24(100.0)

GEM

         

I

0(0.0)

3(100.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

3(100.0)

R

7(5.3)

26(19.8)

55(42.0)

0(0.0)

6(4.6)

26(19.8)

0(0.0)

11(8.3)

131(100.0)

S

0(0.0)

25(22.7)

18(16.4)

1(0.9)

9(8.2)

38(34.5)

2(1.8)

17(15.5)

110(100.0)

TET

    

-

    

R

4(2.4)

39(23.6)

43(26.1)

0(0.0)

-

53(32.1)

1(0.6)

25(15.2)

165(100.0)

S

0(0.0)

1(10.0)

3(30.0)

0(0.0)

-

2(20.0)

0(0.0)

4(40.0)

10(100.0)

COT

    

-

    

I

0(0.0)

1(100.0)

0(0.0)

0(0.0)

-

0(0.0)

0(0.0)

0(0.0)

1(100.0)

R

2(3.5)

19(33.3)

16(28.1)

0(0.0)

-

19(33.3)

0(0.0)

1(1.8)

57(100.0)

S

0(0.0)

3(15.8)

5(26.3)

0(0.0)

-

8(42.1)

0(0.0)

3(15.8)

19(100.0)

AMK

    

-

    

R

0(0.0)

1(5.2)

5(26.3)

0(0.0)

-

10(52.6)

0(0.0)

3(15.8)

19(100.0)

S

6(3.3)

51(28.5)

71(39.7)

0(0.0)

-

23(12.8)

2(1.1)

11(6.1)

179(100.0)

CHL

    

-

    

R

2(5.2)

18(47.3)

15(39.5)

0(0.0)

-

2(5.3)

0(0.0)

1(2.6)

38(100.0)

S

0(0.0)

2(66.7)

1(33.3)

0(0.0)

-

0(0.0)

0(0.0)

0(0.0)

3(100.0)

CTR

    

-

    

R

4(7.4)

17(31.5)

20(37.0)

0(0.0)

-

6(11.1)

0(0.0)

1(1.9)

54(100.0)

S

0(0.0)

10(41.7)

3(12.5)

1(0.2)

-

3(12.5)

0(0.0)

1(1.2)

24(100.0)

CRX

    

-

    

R

4(2.9)

29(20.7)

45(32.1)

0(0.0)

-

38(27.1)

0(0.0)

15(10.7)

140(100.0)

S

0(0.0)

3(13.6)

3(13.6)

0(0.0)

-

11(50.0)

0(0.0)

5(22.7)

22(100.0)

VAN

    

-

    

R

2(3.3)

17(27.9)

21(34.4)

0(0.0)

-

17(27.9)

0(0.0)

4(6.6)

61(100.0)

S

0(0.0)

0(0.0)

2(22.2)

0(0.0)

-

3(33.3)

0(0.0)

4(44.4)

9(100.0)

  1. PEN; Penicillin, COX; Cloxacillin, TET; Tetracycline, COT; GEM; Gentamycin, CIP; Ciprofloxacin, AMK; Amikacin, VAN; Vancomycin, AUG; Augmentin, CHL; Chloramphenicol, CTR; Ceftriaxone, CRX; cefuroxime, MEM; Meropenem